MedTrace Logo

Botswana Tenofovir Oral HIV Prophylaxis Trial

NCT00111150 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2007-03-19

No results posted yet for this study

Summary

This study will test whether taking a pill of tenofovir (an antiretroviral medicine) is safe for sexually-active young adults in Botswana without HIV infection and whether it will reduce their risk of getting an HIV infection.

Conditions

  • HIV Infection

Interventions

DRUG

Tenofovir Disoproxil Fumarate 300 mg daily

Sponsors & Collaborators

Principal Investigators

  • Dawn K Smith, MD, MS, MPH · CDC and BOTUSA

  • Lynn A Paxton, MD, MPH · Centers for Disease Control and Prevention

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
29 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Completion
2007-03-31

Countries

  • United States
  • Botswana

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00111150 on ClinicalTrials.gov